A detailed history of O'Shaughnessy Asset Management, LLC transactions in Scynexis Inc stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 14,912 shares of SCYX stock, worth $17,894. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,912
Previous 28,088 46.91%
Holding current value
$17,894
Previous $56,000 60.71%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1.27 - $2.23 $16,733 - $29,382
-13,176 Reduced 46.91%
14,912 $22,000
Q2 2024

Aug 14, 2024

BUY
$1.4 - $2.77 $17,815 - $35,248
12,725 Added 82.83%
28,088 $56,000
Q1 2024

May 13, 2024

SELL
$1.39 - $2.21 $31,110 - $49,464
-22,382 Reduced 59.3%
15,363 $22,000
Q4 2023

Feb 09, 2024

SELL
$1.56 - $2.24 $5,414 - $7,775
-3,471 Reduced 8.42%
37,745 $84,000
Q3 2023

Nov 13, 2023

BUY
$1.93 - $3.64 $79,546 - $150,026
41,216 New
41,216 $93,000

Others Institutions Holding SCYX

About SCYNEXIS INC


  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $39.2M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.